OPGN Opgen Inc

Price (delayed)

$3.01

Market cap

$4.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$31.36

Enterprise value

$16.85M

OpGen, Inc. (Gaithersburg, MD, USA) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Along with subsidiaries, Curetis GmbH and Ares ...

Highlights
OPGN's EPS has soared by 77% YoY and by 24% QoQ
OPGN's net income is up by 27% YoY and by 19% QoQ
The company's gross margin has shrunk by 163% QoQ but it has surged by 72% YoY
Opgen's gross profit has shrunk by 110% QoQ but it has surged by 75% YoY
The company's quick ratio has shrunk by 97% YoY and by 73% QoQ
OPGN's revenue is down by 22% since the previous quarter and by 12% year-on-year

Key stats

What are the main financial stats of OPGN
Market
Shares outstanding
1.35M
Market cap
$4.06M
Enterprise value
$16.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.3
Earnings
Revenue
$2.67M
EBIT
-$25.32M
EBITDA
-$24.36M
Free cash flow
-$10.91M
Per share
EPS
-$31.36
Free cash flow per share
-$8.5
Book value per share
-$10.7
Revenue per share
$2.08
TBVPS
$2.31
Balance sheet
Total assets
$2.97M
Total liabilities
$13.68M
Debt
$13.06M
Equity
-$10.71M
Working capital
-$11.17M
Liquidity
Debt to equity
-1.22
Current ratio
0.05
Quick ratio
0.03
Net debt/EBITDA
-0.53
Margins
EBITDA margin
-911.2%
Gross margin
-7.1%
Net margin
-993.1%
Operating margin
-538.8%
Efficiency
Return on assets
-234.8%
Return on equity
N/A
Return on invested capital
-340.3%
Return on capital employed
N/A
Return on sales
-947.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPGN stock price

How has the Opgen stock price performed over time
Intraday
2.38%
1 week
-5.94%
1 month
24.9%
1 year
401.67%
YTD
616.67%
QTD
16.67%

Financial performance

How have Opgen's revenue and profit performed over time
Revenue
$2.67M
Gross profit
-$190,114
Operating income
-$14.4M
Net income
-$26.55M
Gross margin
-7.1%
Net margin
-993.1%
The company's gross margin has shrunk by 163% QoQ but it has surged by 72% YoY
Opgen's gross profit has shrunk by 110% QoQ but it has surged by 75% YoY
The company's operating income has surged by 57% YoY and by 19% QoQ
OPGN's operating margin has surged by 51% year-on-year but it is down by 3.7% since the previous quarter

Growth

What is Opgen's growth rate over time

Valuation

What is Opgen stock price valuation
P/E
N/A
P/B
N/A
P/S
1.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.3
OPGN's EPS has soared by 77% YoY and by 24% QoQ
OPGN's equity is up by 7% since the previous quarter
The price to sales (P/S) is 80% lower than the 5-year quarterly average of 7.4 and 19% lower than the last 4 quarters average of 1.8
OPGN's revenue is down by 22% since the previous quarter and by 12% year-on-year

Efficiency

How efficient is Opgen business performance
Opgen's ROA has plunged by 117% YoY and by 24% from the previous quarter
The return on invested capital has dropped by 59% year-on-year and by 19% since the previous quarter
OPGN's ROS is up by 14% YoY but it is down by 5% QoQ

Dividends

What is OPGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPGN.

Financial health

How did Opgen financials performed over time
The company's total assets is 78% lower than its total liabilities
The company's quick ratio has shrunk by 97% YoY and by 73% QoQ
OPGN's current ratio has dropped by 96% year-on-year and by 64% since the previous quarter
The company's debt to equity has shrunk by 180% YoY and by 8% QoQ
OPGN's equity is up by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.